A Rare Presentation of a Newborn with Subcutaneous Fat Necrosis.

A Rare Presentation of a Newborn with Subcutaneous Fat Necrosis. Oman Med J. 2013 Jul;28(4):e054 Authors: Al Shidhani KSH, Al Maani AS, Al Jabri ATJ Abstract Subcutaneous fat necrosis of newborn is a form of panniculitis that often occurs in term and post-term neonate with predisposing risk factors such as perinatal asphyxia and maternal gestational diabetes. A cutaneous involvement may be associated with metabolic complications such as hypoglycemia, hypercalcemia and hypertriglyceridemia. Here, we present a case of Subcutaneous fat necrosis of newborn with bilateral symmetrical involvement of both axillas in a perinatal asphyxiated newborn that has not been previously described in the literature. In this case, there were no major complications apart from asymptomatic hypercalcemia. PMID: 31435476 [PubMed]
Source: Oman Medical Journal - Category: Middle East Health Tags: Oman Med J Source Type: research

Related Links:

Abstract: The US industrial revolution led to a significant increase in the amount of dietary sugar consumed annually. The impact has become a public health crisis over the past several decades. The consequences are seen in the dramatic rise in rates of obesity, type 2 diabetes mellitus, and cardiovascular disease.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: SUGAR CONSUMPTION Source Type: research
The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like peptide (GLP-1) approved for use in the United States. Before Rybelsus, the drug had to be injected.
Source: WebMD Health - Category: Consumer Health News Source Type: news
The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s): Elizabeth Sellers
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
When it came to the cause of death, vitamin D levels were most clearly linked to deaths from diabetes complications.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Diabetes | Endocrinology | Middle East Health | Oman Health | Perinatology & Neonatology